(Vinci Partners) Vinci Partners Investments Ltd. (NASDAQ: VINP) (“Vinci Partners”, “we”, “us” or “our”), the controlling company of a leading alternative investment platform in Brazil, announced today that “Vinci Impacto e Retorno IV”, or “VIR IV” (“the Fund”), the impact family of funds managed by Vinci Partners’ Private Equity strategy, has entered into a definite agreement for the sale of its stake in Pro Infusion (“The Company”), a leading outsourcing company of pharmaceutical compounding services.

VIR IV will sell its stake in The Company to Viveo Group, an ecosystem of companies specialized in each link of the health sector. Viveo Group is acquiring 100% of The Company. The transaction marks the first and full divestment by the Fund in less than two years after its investment.

Since VIR IV’s investment in Pro Infusion, the Fund’s management team has been actively contributing with several initiatives to drive value creation in the Company, following its initial plan of expanding footprint within three fronts: regions, client base and product line, through organic and inorganic growth initiatives. The team has also assisted the Company in the implementation of several corporate and ESG initiatives, such as the implementation of board routines alongside the Company’s managers and the development of a value creation and Impact & ESG plan, by defining and monitoring strategic projects.

José Pano, partner, and Head of the VIR strategy for Vinci Partners, said, “Our team is very pleased with the outcome of our investment in Pro Infusion. The partnership with top-notch entrepreneurs, in one of our focus sectors (healthcare) alongside VIR team support in all major initiatives, allow this full exit to a buyer that will continue with the growing and value-added path of Pro Infusion. This strategic exit delivers a strong DPI for VIR IV in less than two years after our first investment, demonstrating our ability to generate value for our LPs.”

Bruno Zaremba, partner and Chairman of Private Equity and Head of Investor Relations for Vinci Partners, said, “This transaction marks an important milestone for the Impact and Return strategy, being the first divestment of our flagship fund in less than two years. It reassures our capability to generate positive impact in our portfolio companies alongside our ability to return meaningful capital to our LPs.“